Foxg1 Antagonizes Neocortical Stem Cell Progression to Astrogenesis.


Journal

Cerebral cortex (New York, N.Y. : 1991)
ISSN: 1460-2199
Titre abrégé: Cereb Cortex
Pays: United States
ID NLM: 9110718

Informations de publication

Date de publication:
17 12 2019
Historique:
received: 14 03 2018
revised: 06 01 2019
accepted: 09 02 2019
pubmed: 2 3 2019
medline: 5 11 2020
entrez: 2 3 2019
Statut: ppublish

Résumé

Neocortical astrogenesis follows neuronogenesis and precedes oligogenesis. Among key factors dictating its temporal articulation, there are progression rates of pallial stem cells (SCs) towards astroglial lineages as well as activation rates of astrocyte differentiation programs in response to extrinsic gliogenic cues. In this study, we showed that high Foxg1 SC expression antagonizes astrocyte generation, while stimulating SC self-renewal and committing SCs to neuronogenesis. We found that mechanisms underlying this activity are mainly cell autonomous and highly pleiotropic. They include a concerted downregulation of 4 key effectors channeling neural SCs to astroglial fates, as well as defective activation of core molecular machineries implementing astroglial differentiation programs. Next, we found that SC Foxg1 levels specifically decline during the neuronogenic-to-gliogenic transition, pointing to a pivotal Foxg1 role in temporal modulation of astrogenesis. Finally, we showed that Foxg1 inhibits astrogenesis from human neocortical precursors, suggesting that this is an evolutionarily ancient trait.

Identifiants

pubmed: 30821834
pii: 5368120
doi: 10.1093/cercor/bhz031
doi:

Substances chimiques

FOXG1 protein, human 0
Forkhead Transcription Factors 0
Foxg1 protein, mouse 0
Nerve Tissue Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4903-4918

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Carmen Falcone (C)

Laboratory of Cerebral Cortex Development, Neuroscience Area, SISSA, Trieste, Italy.

Manuela Santo (M)

Laboratory of Cerebral Cortex Development, Neuroscience Area, SISSA, Trieste, Italy.

Gabriele Liuzzi (G)

Laboratory of Cerebral Cortex Development, Neuroscience Area, SISSA, Trieste, Italy.

Noemi Cannizzaro (N)

Laboratory of Cerebral Cortex Development, Neuroscience Area, SISSA, Trieste, Italy.

Clara Grudina (C)

Laboratory of Cerebral Cortex Development, Neuroscience Area, SISSA, Trieste, Italy.

Erica Valencic (E)

Department of Diagnostics, Institute for Maternal and Child Health, IRCCS Burlo Garofolo, Trieste, Italy.

Luca Peruzzotti-Jametti (L)

Dept of Clinical Neurosciences, University of Cambridge, Clifford Allbutt Building -- Cambridge Biosciences Campus, Hills Road, Cambridge, UK.

Stefano Pluchino (S)

Dept of Clinical Neurosciences, University of Cambridge, Clifford Allbutt Building -- Cambridge Biosciences Campus, Hills Road, Cambridge, UK.

Antonello Mallamaci (A)

Laboratory of Cerebral Cortex Development, Neuroscience Area, SISSA, Trieste, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH